rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1986-12-31
|
pubmed:abstractText |
We investigated the effect of a thromboxane antagonist, BM 13.177, during endotoxin-induced pulmonary vasoconstriction in sheep. In control animals intravenous E-coli endotoxin (1 microgram/kg) caused a transient increase of pulmonary artery and airway pressure paralleled by large concentration increases of TXB2: in comparison peak plasma concentrations of 6-keto-PGF1 alpha (a prostacyclin metabolite) were small and delayed in time. Pre-treatment with BM 13.177 (bolus 5 mg/kg), followed by 0.75 mg/kg/min intravenously) abolished the rise of pulmonary artery and airway pressure. Plasma concentrations of TXB2 and 6-keto-PGF1 alpha were similar to controls. These and previous investigations imply that BM 13.177 specifically antagonizes TXA2 on the putative receptor in pulmonary vascular and airway smooth muscle.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0144-5979
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
415-22
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3536270-6-Ketoprostaglandin F1 alpha,
pubmed-meshheading:3536270-Animals,
pubmed-meshheading:3536270-Endotoxins,
pubmed-meshheading:3536270-Escherichia coli,
pubmed-meshheading:3536270-Female,
pubmed-meshheading:3536270-Hypertension, Pulmonary,
pubmed-meshheading:3536270-Lung,
pubmed-meshheading:3536270-Sheep,
pubmed-meshheading:3536270-Sulfonamides,
pubmed-meshheading:3536270-Thromboxane A2,
pubmed-meshheading:3536270-Thromboxane B2,
pubmed-meshheading:3536270-Vasoconstriction
|
pubmed:year |
1986
|
pubmed:articleTitle |
Effects of a thromboxane antagonist (BM 13.177) during endotoxin-induced pulmonary vasoconstriction in sheep.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|